These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7618652)

  • 21. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolution of oral hairy leukoplakia during treatment with foscarnet.
    Albrecht H; Stellbrink HJ; Brewster D; Greten H
    AIDS; 1994 Jul; 8(7):1014-6. PubMed ID: 7946089
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of cytomegalovirus retinitis in HIV infection in the era of highly active antiretroviral therapy.
    Timperley A; Taha H; Das S
    Int J STD AIDS; 2015 Sep; 26(10):757-8. PubMed ID: 26232735
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
    Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
    [No Abstract]   [Full Text] [Related]  

  • 25. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA notifications. FDA approves generic foscarnet sodium injection.
    AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563
    [No Abstract]   [Full Text] [Related]  

  • 28. Foscarnet-induced crystalline glomerulonephritis with nephrotic syndrome and acute renal failure after kidney transplantation.
    Zanetta G; Maurice-Estepa L; Mousson C; Justrabo E; Daudon M; Rifle G; Tanter Y
    Transplantation; 1999 May; 67(10):1376-8. PubMed ID: 10360595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of pharmacokinetics and dynamics of two dosage regimens of foscarnet in AIDS patients with Cytomegalovirus retinitis.
    Castelli F; Tomasoni L; Zeroli C; Suter F; Trespi G; Carosi G; Hedman A
    Eur J Clin Pharmacol; 1997; 52(5):397-401. PubMed ID: 9272411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nephrogenic diabetes insipidus associated with foscarnet--a case report.
    Conn J; Colman P; Brown G; Street A; Bate K
    J Antimicrob Chemother; 1996 Jun; 37(6):1179-81. PubMed ID: 8836823
    [No Abstract]   [Full Text] [Related]  

  • 31. Promising new treatments for cytomegalovirus retinitis.
    Polis MA; Masur H
    JAMA; 1995 May; 273(18):1457-9. PubMed ID: 7723160
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group.
    Gerna G; Baldanti F; Sarasini A; Furione M; Percivalle E; Revello MG; Zipeto D; Zella D
    Antimicrob Agents Chemother; 1994 Jan; 38(1):38-44. PubMed ID: 8141577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus retinitis and AIDS in Edinburgh.
    Dhillon B; Maclean H; Eddyshaw D; Cheong I; Flegg P; Brettle R
    Int J STD AIDS; 1993; 4(6):339-41. PubMed ID: 8305575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Care of the patient with AIDS and cytomegalovirus retinitis (continuing education credit).
    Frederick MC
    J Ophthalmic Nurs Technol; 1994; 13(4):156-60; quiz 180-1. PubMed ID: 8064878
    [No Abstract]   [Full Text] [Related]  

  • 35. Care of the patient with AIDS and cytomegalovirus retinitis.
    Frederick MC
    Todays OR Nurse; 1994; 16(5):36-40. PubMed ID: 7974648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy for cytomegalovirus retinitis: still no silver lining.
    Young LH
    JAMA; 1996 Jan; 275(2):149-50. PubMed ID: 8531313
    [No Abstract]   [Full Text] [Related]  

  • 37. The changing treatment options for CMV retinitis.
    Gilden D
    GMHC Treat Issues; 1995; 9(7/8):1-8. PubMed ID: 11362648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CMV retinitis: a clinical management update.
    Blanchet KD
    AIDS Patient Care STDS; 1996 Apr; 10(2):86-93. PubMed ID: 11361712
    [No Abstract]   [Full Text] [Related]  

  • 39. Foscavir receives new indication.
    AIDS Alert; 1997 Jun; 12(6):71. PubMed ID: 11364364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.
    Jacobson MA; Causey D; Polsky B; Hardy D; Chown M; Davis R; O'Donnell JJ; Kuppermann BD; Heinemann MH; Holland GN
    J Infect Dis; 1993 Aug; 168(2):444-8. PubMed ID: 8393058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.